ΔguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin
- 30 April 2000
- Vol. 18 (21) , 2193-2202
- https://doi.org/10.1016/s0264-410x(00)00025-6
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Attenuated ΔguaBA Salmonella typhi Vaccine Strain CVD 915 as a Live Vector Utilizing Prokaryotic or Eukaryotic Expression Systems to Deliver Foreign Antigens and Elicit Immune ResponsesClinical Immunology, 1999
- Are DNA-based vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test caseVaccine, 1998
- DNA VACCINESAnnual Review of Immunology, 1997
- Towards a vaccine candidate againstShigella dysenteriae1: expression of the Shiga toxin B-subunit in an attenuatedShigella flexneri aroDcarrier strainMicrobial Pathogenesis, 1996
- Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strainVaccine, 1995
- Expression of LacZ from thehtrA, nirBandgroEpromoters in aSalmonellavaccine strain: Influence of growth in mammalian cellsFEMS Microbiology Letters, 1995
- Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteersVaccine, 1995
- Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus VaccineNature Biotechnology, 1992
- Prevention of Shigellosis by a Salmonella typhi-Shigella sonnei Bivalent VaccineThe Journal of Infectious Diseases, 1987
- The Response of Man to Virulent Shigella flexneri 2aThe Journal of Infectious Diseases, 1969